Anavex Life Sciences
AVXL
#9708
Rank
NZ$0.18 B
Marketcap
NZ$2.03
Share price
-4.20%
Change (1 day)
-85.02%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2026 (TTM): -NZ$22.19 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$71.06 Million, an increase over its 2024 earnings that were of -NZ$91.6 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$22.19 Million-68.77%
2025 -NZ$71.06 Million-22.43%
2024 -NZ$91.6 Million14.77%
2023 -NZ$79.81 Million-17.49%
2022 -NZ$96.73 Million22.96%
2021 -NZ$78.67 Million35.36%
2020 -NZ$58.12 Million12.65%
2019 -NZ$51.59 Million29.09%
2018 -NZ$39.97 Million36.33%
2017 -NZ$29.32 Million17.11%
2016 -NZ$25.03 Million20.91%
2015 -NZ$20.71 Million-6.29%
2014 -NZ$22.1 Million337.28%
2013 -NZ$5.06 Million
2008 -NZ$9.35 Million106.01%
2007 -NZ$4.54 Million8848.98%
2006 -NZ$0.06 Million-79.99%
2005 -NZ$0.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$0.43 B-1,984.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
NZ$11.37 M-149.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-NZ$11.09 Million-51.81%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$0.68 Billion 2,842.85%๐Ÿ‡บ๐Ÿ‡ธ USA